Bubley GJ - Search Results

1

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor.

Masiello D, Cheng S, Bubley GJ, Lu ML, Balk SP. Masiello D, et al. Among authors: bubley gj. J Biol Chem. 2002 Jul 19;277(29):26321-6. doi: 10.1074/jbc.M203310200. Epub 2002 May 15. J Biol Chem. 2002. PMID: 12015321 Free article.

2

Frequent abnormalities of TSG101 transcripts in human prostate cancer.

Sun Z, Pan J, Bubley G, Balk SP. Sun Z, et al. Oncogene. 1997 Dec 18;15(25):3121-5. doi: 10.1038/sj.onc.1201521. Oncogene. 1997. PMID: 9444960

3

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683

4

Biology of prostate-specific antigen.

Balk SP, Ko YJ, Bubley GJ. Balk SP, et al. Among authors: bubley gj. J Clin Oncol. 2003 Jan 15;21(2):383-91. doi: 10.1200/JCO.2003.02.083. J Clin Oncol. 2003. PMID: 12525533 Review.

5

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. Ko YJ, et al. Among authors: bubley gj. J Urol. 2004 Sep;172(3):1140-4. doi: 10.1097/01.ju.0000134698.87862.e6. J Urol. 2004. PMID: 15311058

6

Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.

Fu XS, Choi E, Bubley GJ, Balk SP. Fu XS, et al. Among authors: bubley gj. Prostate. 2005 May 15;63(3):215-21. doi: 10.1002/pros.20190. Prostate. 2005. PMID: 15538748

7

Imatinib-induced regression of AIDS-related Kaposi's sarcoma.

Koon HB, Bubley GJ, Pantanowitz L, Masiello D, Smith B, Crosby K, Proper J, Weeden W, Miller TE, Chatis P, Egorin MJ, Tahan SR, Dezube BJ. Koon HB, et al. Among authors: bubley gj. J Clin Oncol. 2005 Feb 10;23(5):982-9. doi: 10.1200/JCO.2005.06.079. Epub 2004 Nov 30. J Clin Oncol. 2005. PMID: 15572730 Clinical Trial.

8

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Stanbrough M, et al. Among authors: bubley gj. Cancer Res. 2006 Mar 1;66(5):2815-25. doi: 10.1158/0008-5472.CAN-05-4000. Cancer Res. 2006. PMID: 16510604

9

The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

Yannucci J, Manola J, Garnick MB, Bhat G, Bubley GJ. Yannucci J, et al. Among authors: bubley gj. J Urol. 2006 Aug;176(2):520-5. doi: 10.1016/j.juro.2006.03.057. J Urol. 2006. PMID: 16813881

10

Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.

Yuan X, Li T, Wang H, Zhang T, Barua M, Borgesi RA, Bubley GJ, Lu ML, Balk SP. Yuan X, et al. Among authors: bubley gj. Am J Pathol. 2006 Aug;169(2):682-96. doi: 10.2353/ajpath.2006.051047. Am J Pathol. 2006. PMID: 16877366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters